Worldwide, stroke is the second leading cause of death¹ and occurs when blood supply to the brain is interrupted or reduced, preventing brain tissue from getting oxygen.

At Biogen, we aspire to improve the lives of those suffering from strokes and secondary injuries by developing therapies and solutions to address the areas of greatest unmet need.

By tapping into our connections in the stroke medical community, harnessing our scientific expertise in neurological disorders, and channeling the strength of our pipeline, we’re working to create innovative therapies and digital health solutions that have the potential to transform the standard of care in stroke.

Biogen conducts clinical trials in stroke related to the investigational therapies in our pipeline to evaluate the efficacy and safety of potential medicines.

View all recruiting Biogen clinical trials in stroke

Deciding to participate in a clinical trial requires careful consideration. In most cases, the therapies investigated in clinical trials are not yet approved by regulatory agencies like the U.S. Food and Drug Administration (FDA). The benefits and risks of taking the treatment are not completely known. By volunteering for a clinical trial, you are helping the medical community determine whether new treatments are safe and effective.

Learn more about clinical trials and access programs